SEPARATION OF VIABLE FROM NON-VIABLE TUMOR-CELLS USING FICOLL-HYPAQUE DENSITY SOLUTION

被引：31
作者：
MAVLIGIT, GM
GUTTERMAN, JU
HERSH, EM
机构：
[1] UNIV TEXAS, DEPT DEV THERAPEUTICS, SECT IMMUNOL, HOUSTON, TX 77025 USA
[2] UNIV TEXAS, M D ANDERSON HOSP & TUMOR INST, HOUSTON, TX 77025 USA
来源：
IMMUNOLOGICAL COMMUNICATIONS | 1973年 / 2卷 / 05期
关键词：
D O I：
10.3109/08820137309022818
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：463 / 472
页数：10
相关论文
共 19 条
[1]  
ABELOFF MD, 1970, J LAB CLIN MED, V75, P703
[2]   AN EXTENSION OF 51CR-RELEASE ASSAY FOR ESTIMATION OF MOUSE CYTOTOXINS [J].
BOYLE, W .
TRANSPLANTATION, 1968, 6 (06) :761-&
[3]  
Boyum A., 1968, SCAND J CLIN LAB INV, V97, P7
[4]   The action of vital stains belonging to the benzidine group [J].
Evans, HM ;
Schulemann, W .
SCIENCE, 1914, 39 (01) :443-454
[5]  
HERSH EM, 1970, J RETICULOENDOTH SOC, V7, P567
[6]  
HERSH EM, 1971, CANCER RES, V31, P834
[7]   IMMUNOTHERAPY OF CANCER - AN EXPERIMENTAL MODEL IN SYNGENEIC GUINEA PIGS [J].
KRONMAN, BS ;
WEPSIC, HT ;
CHURCHILL, WH ;
ZBAR, B ;
BORSOS, T ;
RAPP, HJ .
SCIENCE, 1970, 168 (3928) :257-+
[8]   CIRCULATING HUMORAL ANTIBODIES IN CANCER [J].
LEWIS, MG .
MEDICAL CLINICS OF NORTH AMERICA, 1972, 56 (02) :481-+
[9]  
LIVINGSTON R, 1973, P AM ASSOC CANC RES, V14, P54
[10]  
MACDONAL.JL, 1972, P AM ASSOC CANC RES, V13, P75
12